Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

  • There is currently no data for MXCT

MaxCyte News

MaxCyte taps Cenk Sumen as its chief scientific officer
10 Mar 2022

MaxCyte taps Cenk Sumen as its chief scientific officer

(Sharecast News) - Cell engineering company MaxCyte announced the appointment of Cenk Sumen as its chief scientific officer on Thursday.

MaxCyte to consolidate its restricted and unrestricted shares
21 Feb 2022

MaxCyte to consolidate its restricted and unrestricted shares

(Sharecast News) - Cell engineering technology company MaxCyte announced the consolidation of the two lines of its common stock into a single unrestri...

MaxCyte signs platform licence with biotech firm Intima
1 Feb 2022

MaxCyte signs platform licence with biotech firm Intima

(Sharecast News) - Cell engineering platform technology company MaxCyte announced the signing of a strategic platform licence (SPL) with Intima Biosci...

MaxCyte signs strategic platform pact with Intima Bioscience
1 Feb 2022

MaxCyte signs strategic platform pact with Intima Bioscience

MaxCyte signs strategic platform pact with Intima Bioscience

MaxCyte expects improved full-year revenue on organic growth
24 Jan 2022

MaxCyte expects improved full-year revenue on organic growth

MaxCyte expects improved full-year revenue on organic growth

MaxCyte ends year with strong trading
24 Jan 2022

MaxCyte ends year with strong trading

(Sharecast News) - Cell engineering company MaxCyte said on Monday that it expected total revenue for its fourth quarter to be at least $10m, up from ...

UK earnings, trading statements calendar - next 7 days
8 Dec 2021

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

DIRECTOR DEALINGS: New MaxCyte chair buys USD220,000 in shares
23 Nov 2021

DIRECTOR DEALINGS: New MaxCyte chair buys USD220,000 in shares

DIRECTOR DEALINGS: New MaxCyte chair buys USD220,000 in shares